Hemant C. Bhagat

• Chandra Bhagat Pharma's Board approved un-audited H1 FY27 results, reporting a net profit of ₹264.11 lakhs. • Revenue from operations stood at ₹8,012.92 lakhs for the half-year, with earnings per sh